Cbl Monoclonal Antibody
Size: 50μL, 100μL
Catalogue Numbers: RA10896-50, RA10896-100
Citations, Manuals and MSDS Available upon request.
Background: Cbl proto-oncogene (CBL) Homo sapiens This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016],
Condition: Ascitic fluid containing 0.03% sodium azide, 0.5% BSA, 50% glycerol.
Storage Instructions: -20°C/1 year
Applications: WB; IHC-p; IF/ICC; FCM; ELISA
Species Cross-Reactivity: Human; Mouse; Rat
GeneID (Human): 867
SWISS: P22681
Source: Mouse
Research Use Only